naadp has been researched along with muromonab-cd3 in 2 studies
Studies (naadp) | Trials (naadp) | Recent Studies (post-2010) (naadp) | Studies (muromonab-cd3) | Trials (muromonab-cd3) | Recent Studies (post-2010) (muromonab-cd3) |
---|---|---|---|---|---|
411 | 0 | 184 | 85 | 1 | 50 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brailoiu, E; Brailoiu, GC; Deliu, E; Motoc, D; Tica, AA | 1 |
Jiang, YL; Lee, S; Lin, AH; Paudel, O; Ran, P; Sham, JS; Sun, H; Xia, Y; Yang, XR | 1 |
2 other study(ies) available for naadp and muromonab-cd3
Article | Year |
---|---|
Intracellular angiotensin II activates rat myometrium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Arsenicals; Autophagy; Brefeldin A; Calcium Signaling; Carbolines; Cells, Cultured; Egtazic Acid; Endocytosis; Endoplasmic Reticulum; Endosomes; Enzyme Inhibitors; Estrenes; Female; Heparin; Imidazoles; Inositol 1,4,5-Trisphosphate Receptors; Losartan; Lysosomes; Macrocyclic Compounds; Macrolides; Models, Biological; Myometrium; NADP; Oxazoles; Piperazines; Pyridines; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ryanodine; Saralasin; Signal Transduction; Sirolimus; Type C Phospholipases; Uterus | 2011 |
Nicotinic acid adenine dinucleotide phosphate (NAADP) activates global and heterogeneous local Ca2+ signals from NAADP- and ryanodine receptor-gated Ca2+ stores in pulmonary arterial myocytes.
Topics: Animals; Calcium; Calcium Signaling; Carbolines; Endothelin-1; Gene Expression Regulation; Macrocyclic Compounds; Male; Myocytes, Smooth Muscle; NADP; Oxazoles; Piperazines; Pulmonary Artery; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel | 2013 |